1
Injected Ranibizumab to Treat Macular Telangiectasia With New Blood Vessel Formation
Condition(s):TelangiectasiaLast Updated:July 2, 2017Completed
Hide Studies Not Open or Pending
Condition(s):TelangiectasiaLast Updated:July 2, 2017Completed
Condition(s):TelangiectasiaLast Updated:July 2, 2017Completed
Condition(s):Uveomeningoencephalitic Syndrome; Inflammation; Choroid Disease; Visual ImpairmentLast Updated:January 22, 2019Completed
Condition(s):Proliferative Diabetic Retinopathy; VitrectomyLast Updated:August 18, 2008Completed
Condition(s):Purtscher Retinopathy; Pancreatic CancerLast Updated:April 28, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.